Page 52 - GPD-2-1

Gene & Protein in Disease NQO2 and dopamine toxicity versus detoxification

human colon carcinoma cells. Arch Biochem Biophys, cosubstrate specificity of NQO2: Conservation throughout
346: 241–251. the amniotes and implications for cellular function. Front
Pharmacol, 13: 838500.
https://doi.org/10.1006/abbi.1997.0329
https://doi.org/10.3389/fphar.2022.838500
7. Criddle DN, Gillies S, Baumgartner-Wilson HK, et al., 2006,
Menadione-induced reactive oxygen species generation 18. Boutin JA, Bouillaud F, Janda E, et al., 2019, S29434, a
via redox cycling promotes apoptosis of murine pancreatic quinone reductase 2 inhibitor: Main biochemical and
acinar cells. J Biol Chem, 281: 40485–40492. cellular characterization. Mol Pharmacol, 95: 269–285.
https://doi.org/10.1074/jbc.M607704200 https://doi.org/10.1124/mol.118.114231
8. Reybier K, Perio P, Ferry G, et al., 2011, Insights into the 19. Leung KKK, Shilton BH, 2015, Binding of DNA-intercalating
redox cycle of human quinone reductase 2. Free Radic Res, agents to oxidized and reduced quinone reductase 2.
45: 1184–1195. Biochemistry, 54: 7438–7448.
https://doi.org/10.3109/10715762.2011.605788 https://doi.org/10.1021/acs.biochem.5b00884
9. Cassagnes LE, Chhour M, Pério P, et al., 2018, Oxidative 20. Cassagnes LE, Perio P, Ferry G, et al., 2015, In cellulo
stress and neurodegeneration: The possible contribution of monitoring of quinone reductase activity and reactive
quinone reductase 2. Free Radic Biol Med, 120: 56–61. oxygen species production during the redox cycling of 1,2
https://doi.org/10.1016/j.freeradbiomed.2018.03.002 and 1,4 quinones. Free Radic Biol Med, 89: 126–134.
10. Vella F, Ferry G, Delagrange P, et al., 2005, NRH: quinone https://doi.org/10.1016/j.freeradbiomed.2015.07.150
reductase 2: An enzyme of surprises and mysteries. Biochem 21. Crocker AD, 1994, Experimental and clinical pharmacology:
Pharmacol, 71: 1–12. Dopamine- mechanisms of action. Aust Prescr, 17: 17–21.
https://doi.org/10.1016/j.bcp.2005.09.019 https://doi.org/10.18773/austprescr.1994.023
11. Janda E, Nepveu F, Calamini B, et al., 2020, Molecular 22. Nasrolahi A, Javaherforooshzadeh F, Jafarzadeh-
pharmacology of NRH: Quinone oxidoreductase 2: a Gharehziaaddin M, et al., 2022, Therapeutic potential of
detoxifying enzyme acting as an undercover toxifying neurotrophic factors in Alzheimer’s disease. Mol Biol Rep,
enzyme. Mol Pharmacol, 98: 620–33. 49: 2345–2357.
https://doi.org/10.1124/molpharm.120.000105 https://doi.org/10.1007/s11033-021-06968-9
12. Liao S, Dulaney JT, Williams-Ashman HG, 1962, Purification 23. Grosset D, 2010, Therapy adherence issues in Parkinson’s
and properties of a flavoprotein catalyzing the oxidation of disease. J Neurol Sci, 289: 115–118.
reduced ribosyl nicotinamide. J Biol Chem, 237: 2981–2987.
https://doi.org/10.1016/j.jns.2009.08.053
13. Zhao Q, Yang XL, Holtzclaw WD, et al., 1997, Unexpected 24. Miyazaki I, Asanuma M, 2009, Approaches to prevent
genetic and structural relationships of a long-forgotten dopamine quinone-induced neurotoxicity. Neurochem Res,
flavoenzyme to NAD(P)H: quinone reductase 34: 698–706.
(DT-diaphorase). Proc Natl Acad Sci U S A, 94: 1669–1674.
https://doi.org/10.1007/s11064-008-9843-1
https://doi.org/10.1073/pnas.94.5.1669
25. Smythies JR, 1997, Oxidative reactions and schizophrenia:
14. Formentini L, Moroni F, Chiarugi A, 2009, Detection A review-discussion. Schizophr Res, 24: 357–364.
and pharmacological modulation of nicotinamide
mononucleotide (NMN) in vitro and in vivo. Biochem https://doi.org/10.1016/s0920-9964(97)00005-4
Pharmacol, 77: 1612–1620. 26. Latif S, Jahangeer M, Maknoon Razia D, et al., 2021, Dopamine
https://doi.org/10.1016/j.bcp.2009.02.017 in Parkinson’s disease. Clin Chim Acta, 522: 114–126.
15. Sonavane M, Hayat F, Makarov M, et al., 2020, https://doi.org/10.1016/j.cca.2021.08.009
Dihydronicotinamide riboside promotes cell-specific 27. Zhu L, Sun C, Ren J, et al., 2019, Stress-induced precocious
cytotoxicity by tipping the balance between metabolic aging in PD-patient iPSC-derived NSCs may underlie the
regulation and oxidative stress. PLoS One, 15: e0242174.
pathophysiology of Parkinson’s disease. Cell Death Dis,
https://doi.org/10.1371/journal.pone.0242174 10: 105.
16. Makarov MV, Hayat F, Graves B, et al., 2021, Chemical and https://doi.org/10.1038/s41419-019-1313-y
biochemical reactivity of the reduced forms of Nicotinamide 28. Best JA, Nijhout HF, Reed MC, 2009, Homeostatic
riboside. ACS Chem Biol, 16: 604–614.
mechanisms in dopamine synthesis and release:
https://doi.org/10.1021/acschembio.0c00757 A mathematical model. Theor Biol Med Model, 6: 21.
17. Islam F, Leung KK, Walker MD, et al., 2022, The unusual https://doi.org/10.1186/1742-4682-6-21

Volume 2 Issue 1 (2023) 6 https://doi.org/10.36922/gpd.227